Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_ebook_updated-0723-FINAL-1
Natural History - Case Study: Ultra Rare Disease in Subjects Aged 3 Years and Younger

Pharm-Olam is a clinical research organization (CRO) with global reach and deep expertise in rare disease research. Our...


(3 minute read)

Tags: Rare & Orphan Disease

The Future of Rare Disease Research

Pharm-Olam has been taking a closer look at trends in rare disease research. We started off by reviewing an article that was...


(4 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

The Use of Drug Repurposing in Rare Disease Research

At Pharm-Olam, we have been focusing on trends in rare disease research. We reviewed an article from Nature (click here to...


(4 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

The Use of Gene Therapies in Rare Disease Research

At Pharm-Olam, we go the distance in rare disease. Recently, we have been exploring the subject in greater detail. We started...


(4 minute read)

Tags: Rare & Orphan Disease

The Use of Oligonucleotide Therapies in Rare Disease Research

Rare disease research is such a complicated area because it involves every therapeutic area individually and sometimes in...


(4 minute read)

Tags: Rare & Orphan Disease

The Use of Protein Replacement Therapies in Rare Disease Research

Rare disease research can take many forms, and each drug development platform offers specific advantages researchers can...


(4 minute read)

Tags: Rare & Orphan Disease

The Use of Antibody Therapy in Rare Disease Research

In this article, we continue our look into rare disease research. Earlier, we began our examination of the subject (read the...


(4 minute read)

Tags: Rare & Orphan Disease

Trends in Small Molecule Rare Disease Research

Earlier this week, we looked at rare disease research in the broadest terms (read the article here). We explained that rare...


(3 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover